Peer-reviewed, legible, interoperable clinical trial data, shared openly with patients and practitioners in mind.
You made it so simple. Our trial design is so much better now.
CRC - Brain360
Clinical Trial Data Notes exists to improve outcomes for patients and sponsors by increasing the volume, quality, and utility of data available to all members of the clinical trial ecosystem.
Our focus spans data on clinical results, operations, methodology, and trends, with the end goal of making clinical trial data as a domain more comprehensible and interoperable.
All publications will adhere to our Data Descriptor article, with a particular emphasis on datasets that build upon already-open data. Data are made available via CTDNDB and reviewed to ensure alignment with FAIR Principles.
Participant Ethnicity in Rheumatoid Arthritis Clinical Trials
"The modulating role of HLA-DRB1 in the severity of rheumatoid arthritis was first documented nearly 30 years ago. Since then..."Continue Reading
Adverse Event Profiles in Estrogen Receptor Positive Breast Cancer
"The past 10 years have seen rapid advances in treatment of estrogren receptor positive breast cancer, corresponding with..."Continue Reading
Standardized Outcome Data in Refractory Multiple Myeloma
Amet minim mollit non deserunt ullamco est sit aliqua dolor do amet sint. Velit officia consequat duis enim velit mollit.Continue Reading
Currently we only accept Data Notes. View our submission guidelines here.
To date, our median time to acceptance is 61 days.
Amet minim mollit non deserunt ullamco est sit aliqua dolor do amet sint. Velit officia consequat duis enim velit mollit. Exercitation veniam consequat sunt nostrud amet.
This is a low-risk study. There are no hazardous chemicals in the kit that we'll ship you, and the sampling process is safe.
policies & governance
© Copyright 2022, All Rights Reserved by JoCRA